The earnings call highlighted significant challenges, including a major decline in revenue and gross margin, alongside an increased net loss. Despite these challenges, there were positive developments in the personal health segment, strategic partnerships, and AI initiatives. However, the financial setbacks appear to overshadow the positive developments.

Company Guidance

During the Ekso Bionics Second Quarter 2025 Financial Results Conference Call, the company reported a disappointing revenue of $2.1 million, a significant drop from $5 million in the same quarter of 2024, primarily due to short-term delays in completing multi-device Enterprise Health sales. Despite this decline, Ekso Indego Personal device sales partially offset the loss. Gross profit for Q2 2025 was $800,000, with a gross margin of approximately 40%, down from a gross profit of $2.6 million and a gross margin of 53% in Q2 2024. Operating expenses were reduced by 4% to $4.8 million. The net loss applicable to common stockholders increased to $2.7 million or $1.24 per share, from $2.4 million or $1.99 per share in the previous year. The company held $5.2 million in cash and restricted cash as of June 30, 2025. Ekso remains optimistic about closing deferred sales and expects Personal Health product revenues to grow significantly, having already increased by over 50% in the first half of 2025 compared to the previous year.

Growth in Personal Health Segment

Personal Health product revenues grew by more than 50% year-over-year in the first half of 2025, driven by the Ekso Indego Personal device.

Strategic Partnerships and Initiatives

Ekso Bionics established a partnership with PRIA Healthcare for market access and received the first order from National Seating & Mobility as an exclusive distributor. They also launched eksoUniversity for education.

AI and Innovation Initiatives

Ekso joined the NVIDIA Connect program to integrate AI capabilities, resulting in an initial proof of concept AI voice agent for intelligent control of their EksoNR device.

EKSO BIONICS (EKSO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

EKSO Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	-0.96 / -	-1.5	―	―	―
Jul 28, 2025	2025 (Q2)	-1.35 / -1.24	-1.95	36.41% (+0.71)
May 05, 2025	2025 (Q1)	-1.65 / -1.80	-3	40.00% (+1.20)	―
Mar 03, 2025	2024 (Q4)	-1.20 / -2.10	-3.3	36.36% (+1.20)	―
Oct 28, 2024	2024 (Q3)	-1.57 / -1.50	-3.6	58.33% (+2.10)	―
Jul 29, 2024	2024 (Q2)	-1.95 / -1.95	-4.65	58.06% (+2.70)	―
Apr 29, 2024	2024 (Q1)	-2.40 / -3.00	-4.95	39.39% (+1.95)
Mar 04, 2024	2023 (Q4)	-1.65 / -3.30	-3.6	8.33% (+0.30)	―
Oct 26, 2023	2023 (Q3)	-4.65 / -3.60	-4.95	27.27% (+1.35)	―
Jul 27, 2023	2023 (Q2)	-4.20 / -4.65	-3.45	-34.78% (-1.20)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

EKSO Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 28, 2025	$4.53	$3.29	-27.37%
May 05, 2025	$7.15	$6.50	-9.09%
Mar 03, 2025	$7.23	$7.14	-1.24%
Oct 28, 2024	$16.95	$14.40	-15.04%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does EKSO BIONICS (EKSO) report earnings?

EKSO BIONICS (EKSO) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).

What is EKSO BIONICS (EKSO) earnings time?

EKSO BIONICS (EKSO) earnings time is at Oct 30, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is EKSO EPS forecast?

EKSO EPS forecast for the fiscal quarter 2025 (Q3) is -0.97.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing